Literature DB >> 23956952

Phenotypic Categorization and Profiles of Small and Large Hepatocellular Carcinomas.

Petr Pancoska1, Sheng-Nan Lu, Brian I Carr.   

Abstract

We used a database of 4139 Taiwanese HCC patients to take a new approach (Network Phenotyping Strategy) to HCC subset identification. Individual parameters for liver function tests, complete blood count, portal vein thrombosis, AFP levels and clinical demographics of age, gender, hepatitis or alcohol consumption, were considered within the whole context of complete relationships, being networked with all other parameter levels in the entire cohort. We identified 4 multi-parameter patterns for one tumor phenotype of patients and a separate 5 multi-parameter patterns to characterize another tumor phenotype of patterns. The 2 subgroups were quite different in their clinical profiles. The means of the tumor mass distributions in these phenotype subgroups were significantly different, one being associated with larger (L) and the other with smaller (S) tumor masses. These significant differences were seen systematically throughout the tumor mass distributions. Essential and common clinical components of L-phenotype patterns included simultaneously high blood levels of AFP and platelets plus presence of portal vein thrombosis. S included higher levels of liver inflammatory parameters. The 2 different parameter patterns of L and S subgroups suggest different mechanisms; L, possibly involving tumor-driven processes and S more associated with liver inflammatory processes.

Entities:  

Keywords:  AFP; HCC; Portal vein thrombosis; Tumor mass

Year:  2013        PMID: 23956952      PMCID: PMC3745219          DOI: 10.4172/2161-069X.S12-001

Source DB:  PubMed          Journal:  J Gastrointest Dig Syst


  16 in total

1.  Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.

Authors:  K Tanaka; H Sakai; M Hashizume; T Hirohata
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

2.  Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.

Authors:  Sheng-Nan Lu; Jing-Houng Wang; Shiann-Long Liu; Chao-Hung Hung; Chien-Hung Chen; Hung-Da Tung; Tsung-Ming Chen; Wu-Shiung Huang; Chuan-Mo Lee; Chia-Cheng Chen; Chi-Sin Changchien
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

Review 3.  Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.

Authors:  Tohru Utsunomiya; Mitsuo Shimada; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Masaki Mori
Journal:  J Gastroenterol       Date:  2009-12-08       Impact factor: 7.527

Review 4.  [Hepatocellular carcinoma. Rare forms of presentation].

Authors:  J C Rosa; P Chaves; J M de Almeida; J Soares
Journal:  Acta Med Port       Date:  1995-04

5.  Hepatocellular carcinoma without cirrhosis in Japanese patients.

Authors:  K Okuda; T Nakashima; M Kojiro; Y Kondo; K Wada
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

6.  Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.

Authors:  Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; Yasuhiro Hisanaga; Akira Kanamori; Hiroyuki Atsumi; Makiko Takagi; Takahiro Arakawa; Masashi Fujimori
Journal:  J Med Virol       Date:  2010-04       Impact factor: 2.327

7.  Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.

Authors:  Brian I Carr; Vito Guerra; Petr Pancoska
Journal:  Oncology       Date:  2012-09-18       Impact factor: 2.935

8.  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Authors:  Anna S Lok; Leonard B Seeff; Timothy R Morgan; Adrian M di Bisceglie; Richard K Sterling; Teresa M Curto; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Zachary D Goodman
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

9.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

10.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Authors:  F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

View more
  6 in total

1.  Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.

Authors:  Petr Pancoska; Brian I Carr; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani
Journal:  Semin Oncol       Date:  2014-04-24       Impact factor: 4.929

2.  Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis.

Authors:  Petr Pančoška; Lubomír Skála; Jaroslav Nešetřil; Brian I Carr
Journal:  Semin Oncol       Date:  2015-01-05       Impact factor: 4.929

3.  Macro- and micro-environmental factors in clinical hepatocellular cancer.

Authors:  Petr Pancoska; Brian I Carr
Journal:  Semin Oncol       Date:  2014-03-07       Impact factor: 4.929

4.  A simple 2-parameter blood test alert for the presence of small hepatocellular carcinomas.

Authors:  Brian I Carr; Harika Gozukara Bag; Volkan Ince; Zeki Ogut; Adem Tuncer; Sami Akbulut; Veysel Ersan; Sertac Usta; Burak Isik; Sezai Yilmaz
Journal:  Clin Pract (Lond)       Date:  2021

5.  A Combination of Blood Lymphocytes and AST Levels Distinguishes Patients with Small Hepatocellular Carcinomas from Non-cancer Patients.

Authors:  Brian I Carr; Harika Gozukara Bag; Volkan Ince; Sami Akbulut; Veysel Ersan; Sertac Usta; Burak Isik; Zeki Ogut; Adem Tuncer; Sezai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2021-11-11

6.  A Liver Index and its Relationship to Indices of HCC Aggressiveness.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Alberto Masotto; Franco Trevisani
Journal:  J Integr Oncol       Date:  2016-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.